Podcast
Questions and Answers
What is the purpose of Recommendation Table 3?
What is the purpose of Recommendation Table 3?
Where would you most likely find information about the treatment of symptomatic heart failure with mildly reduced ejection fraction?
Where would you most likely find information about the treatment of symptomatic heart failure with mildly reduced ejection fraction?
What aspect of heart failure does Recommendation Table 2 focus on?
What aspect of heart failure does Recommendation Table 2 focus on?
Which section would you refer to for information on data availability?
Which section would you refer to for information on data availability?
Signup and view all the answers
What is NOT covered in the Recommendation Tables mentioned in the text?
What is NOT covered in the Recommendation Tables mentioned in the text?
Signup and view all the answers
Which section is likely to contain information about authors' credentials?
Which section is likely to contain information about authors' credentials?
Signup and view all the answers
If you are looking for additional resources related to the content, which section should you refer to?
If you are looking for additional resources related to the content, which section should you refer to?
Signup and view all the answers
What term did the Task Force consider changing to HFnEF, but ultimately decided to keep as HFpEF?
What term did the Task Force consider changing to HFnEF, but ultimately decided to keep as HFpEF?
Signup and view all the answers
What type of outcomes did the Task Force focus on when assigning recommendations?
What type of outcomes did the Task Force focus on when assigning recommendations?
Signup and view all the answers
In most HF trials, what is the correct convention for describing the composite primary endpoint?
In most HF trials, what is the correct convention for describing the composite primary endpoint?
Signup and view all the answers
What type of trials involved a composite outcome that included total (first and repeat) HF hospitalizations and all CV deaths?
What type of trials involved a composite outcome that included total (first and repeat) HF hospitalizations and all CV deaths?
Signup and view all the answers
Which term was considered by the Task Force for changing to HFnEF?
Which term was considered by the Task Force for changing to HFnEF?
Signup and view all the answers
What change did the Task Force discuss regarding the description of HF with preserved ejection fraction?
What change did the Task Force discuss regarding the description of HF with preserved ejection fraction?
Signup and view all the answers
In assigning recommendations, what part of the trials did the Task Force primarily focus on?
In assigning recommendations, what part of the trials did the Task Force primarily focus on?
Signup and view all the answers
What level of recommendation did the Task Force make for the use of disease-modifying therapies in HFmrEF?
What level of recommendation did the Task Force make for the use of disease-modifying therapies in HFmrEF?
Signup and view all the answers
Which type of trials formed the basis for recommendations for HFmrEF according to the text?
Which type of trials formed the basis for recommendations for HFmrEF according to the text?
Signup and view all the answers
What type of therapies had class I evidence for use in HFrEF according to the text?
What type of therapies had class I evidence for use in HFrEF according to the text?
Signup and view all the answers
What class of recommendation did the Task Force provide for the use of SGLT2 inhibitors?
What class of recommendation did the Task Force provide for the use of SGLT2 inhibitors?
Signup and view all the answers
Which type of patients had no recommendations provided for disease-modifying HFrEF therapies?
Which type of patients had no recommendations provided for disease-modifying HFrEF therapies?
Signup and view all the answers
Which class of therapies failed to meet their primary endpoints in clinical trials according to the text?
Which class of therapies failed to meet their primary endpoints in clinical trials according to the text?
Signup and view all the answers
'For those with HFmrEF, with LVEF between 41% and 49%', what is the key parameter mentioned?
'For those with HFmrEF, with LVEF between 41% and 49%', what is the key parameter mentioned?
Signup and view all the answers
What is the recommended class of medication for patients with HFpEF to reduce the risk of HF hospitalization or CV death?
What is the recommended class of medication for patients with HFpEF to reduce the risk of HF hospitalization or CV death?
Signup and view all the answers
According to the guidelines, what was the significant reduction observed in patients with HFpEF who took SGLT2 inhibitors?
According to the guidelines, what was the significant reduction observed in patients with HFpEF who took SGLT2 inhibitors?
Signup and view all the answers
In patients with HFpEF, what endpoint was reduced by the use of SGLT2 inhibitors as per the guidelines?
In patients with HFpEF, what endpoint was reduced by the use of SGLT2 inhibitors as per the guidelines?
Signup and view all the answers
Which type of heart failure does the guideline specifically focus on in relation to SGLT2 inhibitor recommendation?
Which type of heart failure does the guideline specifically focus on in relation to SGLT2 inhibitor recommendation?
Signup and view all the answers
What is the significance of the reduction observed in HF hospitalizations and not CV death when taking SGLT2 inhibitors?
What is the significance of the reduction observed in HF hospitalizations and not CV death when taking SGLT2 inhibitors?
Signup and view all the answers
Which trials were used as evidence for the recommendation of SGLT2 inhibitors in HFpEF patients?
Which trials were used as evidence for the recommendation of SGLT2 inhibitors in HFpEF patients?
Signup and view all the answers
What does the Class I A level of recommendation indicate for the use of SGLT2 inhibitors in HFpEF patients?
What does the Class I A level of recommendation indicate for the use of SGLT2 inhibitors in HFpEF patients?
Signup and view all the answers
What eGFR range was considered for CKD in the DAPA-CKD trial?
What eGFR range was considered for CKD in the DAPA-CKD trial?
Signup and view all the answers
What urinary albumin-to-creatinine ratio range was considered for CKD in the FIDELIO-DKD trial?
What urinary albumin-to-creatinine ratio range was considered for CKD in the FIDELIO-DKD trial?
Signup and view all the answers
What was the treatment recommended for iron deficiency in the 2021 ESC HF Guidelines?
What was the treatment recommended for iron deficiency in the 2021 ESC HF Guidelines?
Signup and view all the answers
What eGFR range was considered for CKD in the EMPA-KIDNEY trial?
What eGFR range was considered for CKD in the EMPA-KIDNEY trial?
Signup and view all the answers
What was the common urinary albumin-to-creatinine ratio requirement for CKD across the trials mentioned?
What was the common urinary albumin-to-creatinine ratio requirement for CKD across the trials mentioned?
Signup and view all the answers
What did the IRONMAN trial focus on?
What did the IRONMAN trial focus on?
Signup and view all the answers
In which trial were patients considered for CKD if they had an eGFR 25–60 mL/min/1.73 m2 and diabetic retinopathy?
In which trial were patients considered for CKD if they had an eGFR 25–60 mL/min/1.73 m2 and diabetic retinopathy?
Signup and view all the answers
What effect was ferric carboxymaltose recommended to have according to the 2021 ESC HF Guidelines?
What effect was ferric carboxymaltose recommended to have according to the 2021 ESC HF Guidelines?
Signup and view all the answers
Which one is considered as iron deficiency in terms of eGFR in FIDELIO-DKD trial?
Which one is considered as iron deficiency in terms of eGFR in FIDELIO-DKD trial?
Signup and view all the answers
